Psychedelic medicine: a re-emerging therapeutic paradigm
Canadian Medical Association Journal – September 08, 2015
Source: OpenAlex
Summary
A compelling shift is underway in Medicine: clinical psychology and psychiatry are re-examining psychedelics for treating severe mental health conditions. After decades, drug studies are exploring how these substances, often derived from chemical synthesis and alkaloids, influence neurotransmitter receptors to alleviate anxiety, addiction, posttraumatic stress, and depression. Psychotherapists are particularly interested in their potential. This renewed focus offers new hope for millions struggling with these debilitating illnesses, marking a significant development in our understanding of brain function and therapeutic approaches.
Abstract
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the